RAvulizumab to PRotect PaTients with Chronic Kidney DisEase (CKD) froM Cardiac Surgery Associated Acute Kidney Injury (CSA-AKI)

RAvulizumab to PRotect PaTients with Chronic Kidney DisEase (CKD) froM Cardiac Surgery Associated Acute Kidney Injury (CSA-AKI) and Subsequent Major Adverse Kidney Events (MAKE): A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study

Open

Protocol code: ALXN1210-CSA-AKI-318
EudraCT code: No aplica
Research group: Shock, Organ Dysfunction and Resuscitation
Service: RTA ICU
Principal investigator: Ferrer Roca, Ricard
Pathology: Símptomes, signes i troballes anormals clíniques i de laboratori, no classificades enlloc més
Phase: Fase III
Status: Recruiting volunteers